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Sustained hyperosmolarity increses TGF-ß1
and Egr-1 expression in the rat renal
medulla
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Abstract
Background: Although TGF-ß and the transcription factor Egr-1 play an important role in both kidney fibrosis and
in response to acute changes of renal medullary osmolarity, their role under sustained hypo- or hyperosmolar
conditions has not been elucidated. We investigated the effects of chronic hypertonicity and hypotonicity on the
renal medullary TGF-ß and Egr-1 expression.
Methods: Male adult Sprague Dawley rats (n = 6/group) were treated with 15 mg/day furosemide, or the rats were
water restricted to 15 ml/200 g body weight per day. Control rats had free access to water and rodent chow.
Kidneys were harvested after 5 days of treament.
In cultured inner medullary collecting duct (IMCD) cells, osmolarity was increased from 330 mOsm to 900 mOsm
over 6 days. Analyses were performed at 330, 600 and 900 mOsm.
Results: Urine osmolarity has not changed due to furosemide treatment but increased 2-fold after water restriction
(p < 0.05). Gene expression of TGF-ß and Egr-1 increased by 1.9-fold and 7-fold in the hypertonic medulla,
respectively (p < 0.05), accompanied by 6-fold and 2-fold increased c-Fos and TIMP-1 expression, respectively
(p < 0.05) and positive immunostaining for TGF-ß and Egr-1 (p < 0.05).
Similarly, hyperosmolarity led to overexpression of TGF-ß and Egr-1 mRNA in IMCD cells (2.5-fold and 3.5-fold
increase from 330 to 900 mOsm, respectively (p < 0.05)) accompanied by significant c-Fos and c-Jun
overexpressions (p < 0.01), and increased Col3a1 and Col4a1 mRNA expression.
Conclusion: We conclude that both TGF-ß and Egr-1 are upregulated by sustained hyperosmolarity in the rat renal
medulla, and it favors the expression of extracellular matrix components.
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Background
Chronic kidney disease counts for a significant
number of deaths worldwide, and its prevalence is
estimated to be 8–16% [1]. The pathomechanisms of
glomerulosclerosis and tubulointerstitial fibrosis show
many similarities irrespective of the etiology (eg.
diabetes mellitus, hypertension, etc.) [2].
Tranforming growth factor-ß (TGF-ß) has a major
impact on fibrotic diseases, including myocardial, pul-
monary and kidney fibrosis [3–6]. TGF-ß is present
in the inner medulla of humans and rats, inhibiting
sodium transport by the inner medullary collecting
duct (IMCD) cells [7–10]. High water intake amelio-
rates tubulointerstitial injury by reducing TGF-ß
mRNA expression in the medullary interstitium [11],
whereas high salt diet in Sprague Dawley rats
increased the renal expression and urinary excretion
of TGF-ß, without altering plasma TGF-ß levels [12].
In renal fibroblasts, acute increase of hyperosmolarity
resulted in TGF-ß activation in vitro [13]. TGF-ß can
induce the transcription of several genes, including
the transcription factors Egr-1 (early growth response
factor-1) and the activator protein-1 (AP-1), which
has been associated with upregulation of extracellular
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matrix production [14–16]. AP-1 can induce extracel-
lular matrix accumulation also through the activation
of the tissue inhibitor of metalloprotease-1 (TIMP-1)
expression [17]. Short term osmotic stress has been
reported to upregulate Egr-1 [18–20] in vitro but lit-
tle is known about its role in the renal medulla. The
transcription factor AP-1 is a heterodimeric molecule,
composed of Jun and Fos nuclear oncoprotein
families, being c-Jun and c-Fos the two major compo-
nents of AP-1 [21].
As sustained hypertonicity is present in the renal me-
dulla, we aimed to investigate how altered medullary
osmolarity (by increasing or decreaseing solute) might
affect TGF-ß, Egr-1 and AP-1 expressions. We examined
hyperosmolar medulla by 60% water restriction, which
resulted in avid distal tubule reabsorption thus increased
medullary tonicity. Hypoosmolar medulla was achieved
by furosemide treatment to increase urine flow rate and
deplete medullary solute [22]. We have also confirmed
our in vivo results on murine inner medullary collecting
duct (IMCD) cells cultured at 330, 600 and 900 mOsm.
Methods
Animals
Eighteen male Sprague-Dawley rats weighing 250 to
300 g (Crl:SD, Charles River, Sulzfeld, Germany) were
housed individually in polycarbonate cages (Type
1290 L, Tecniplast, Buguggiate, Italy) in a barrier room
at a constant temperature of 22 ± 2 °C with 12 h light/
dark cycles. The number of animals was calculated by
the Ethical Committee to provide the minimum sample
size needed for relevant results. Rats were randomly dis-
tributed into three experimental groups. Standard rodent
chow and water access varied according to the experi-
mental groups, as follows:
Control rats (n = 6) received 15 g chow and 18.5 ml of
water per 100 g of body weight; Water restriction group
(n = 6) received 15 g chow and 7.5 ml of water per
100 g of body weight; rats in the Furosemide group
(n = 6) had access to chow and water ad libitum, but
were treated with furosemide (at a dose of 5 mg/kg)
twice daily for 5 days [22], and also had free access to
0.8% NaCl/0.1% KCl drinking water to replace salt
losses.
Twenty-four hour collected urine samples were
obtained using metabolic cages (Tecniplast). Baseline
collected urine and blood samples from retroorbital
plexus were collected on the first day at 8 AM, and re-
peatedly on day 5 at 8 AM, when kidneys were harvested
after euthanasia with carbon dioxide in a closed con-
tainer. The medulla and cortex of the right kidney were
separated and snap frozen, while the left kidney was cut
in half and fixed in 4% buffered formalin solution over-
night, then embedded in paraffin.
Urine chemistries
Urine samples were collected for 24 h in metabolic cages
at day 0 and day 7 of the study, and urine volume (V)
was determined. Urine creatinine concentrations were
measured photometrically using commercial kits
(Diagnosztikum Zrt, Budapest, Hungary). Urine protein
concentration was measured (BCA Protein Assay, Pierce
Thermo Scientific, Rockford, USA), and urine protein/
creatinine ratios were calculated. Urine osmolarity
(Osmurine) was measured by standard laboratory
osmometer in the Central Laboratory of Semmelweis
University and the amount of daily excreted osmotic
material (mOsm/24 h) was calculated as: Osmurine
(mOsm/l) x V (liter/24 h).
Renal immunohistochemistry
Immunohistochemistry was performed on formalin
fixed, paraffin embedded sections, using the avidin-
biotin method, as previously described [23]. Briefly,
after antigen retrieval in citric buffer, slides were
incubated overnight at 4 °C with rabbit polyclonal
anti-TGF-β1 (1:100; Santa Cruz Biotechnology, Santa
Cruz, CA, USA) or rabbit polyclonal EGR-1 (1:400,
Cell Signaling Technologies) antibodies. Secondary
antibodies (SuperSensitive Link) were purchased from
BioGenex (San Ramon, CA, USA). The slides were
developed with Liquid Permanent Red (Dako). Nega-
tive controls for all immunostainings were performed
by omitting the primary antibodies. Nuclei were
counterstained with hematoxylin solution, then slides
were mounted using Aquatex (Merck) and analyzed
under light microscope.
Immunohistochemical staining of the inner and outer
medulla was examined at a magnification of ×400 count-
ing the number of positive cells per field in each section,
as described previously [23]. All samples were evaluated
in a blind manner.
Cell culture of inner medullary collecting duct (IMCD)
cells
Murine IMCD cells (mIMCD-3) were purchased from
American Type Culture Collection (ATCC Catalogue#
CRL-2123, Manassas, VA, USA) and maintained in
Dulbecco’s modified Eagle’s medium (DMEM, Sigma-
Aldrich, Budapest, Hungary) containing 1 g/l glucose
supplemented with 10% fetal bovine serum (Gibco, Life
Technologies, USA), 4 mM glutamine and 100 IU/ml
penicillin and 100 μg/ml streptomycin (Gibco) and
cultured for at 37 °C in 5% CO2 atmosphere.
IMCD cells were plated on 6 cm dishes (500,000 cell/
dish) and cultured in DMEM/F12 medium (Sigma-Al-
drich) containing 10% FBS and antibiotics. For the MTT
assay, cells were plated on 96-well plates (25,000 cells/
well). After confluency, the medium was switched to
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serum-free DMEM/F12 medium supplemented with
3,3′,5-Triiodo-L-thyronine (T3, Sigma-Aldrich), insulin-
transferrin-selenium (ITS-G, Gibco), Bovine Serum
Albumin (Sigma-Aldrich) and hydrocortisone (Sigma-
Aldrich). In order to mimic the hyperosmolar conditions
of the renal medulla, the medium osmolarity was
gradually increased by adding NaCl and urea, from
330 mOsm reaching 900 mOsm on day 7. At specific os-
molarities (330, 600, 900 mOsm), cells were harvested
for MTT assay (on 96-well plates, n = 8 replicates/
group), RNA and protein isolation (on 6 cm dishes,
n = 4 replicates/group).
MTT viability assay
To estimate the number of viable cells 3-(4,5-di-
methyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium brom-
ide (MTT) was used. First the cells were dissociated
with 0.05 mM EDTA (at a final concentration of
2.5 μM) at 37 °C for 15 min at 5% CO2 atmosphere
to allow complete dye uptake, then FBS containing 3-
(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium
bromide (MTT, Calbiochem, EMD BioSciences, San
Diego, CA, USA) was added in 1/10 volume to reach
final concentration of 0.5 mg/mL, and the cells were
incubated for 3 h at 37 °C at 5% CO2 atmosphere
[24]. Cells were washed with PBS, dried overnight at
room temperature and the formazan dye was
dissolved in isopropanol. The amount of converted
formazan dye was measured at 570 nm with back-
ground measurement at 690 nm on a Powerwave
reader (Biotek). The calibration curve created with
serial dilutions of IMCD cells was used to calculate
the viable cell count with the Gen5 data reduction
software (Biotek, Winooski, VT, USA).
Immunocytochemistry
IMCD cells (5000 cells/well) were seeded on BD mul-
tichamber slides and underwent the gradual increase
in osmolarity as described above. At 330, 600 and
900 mOsm, cells were washed with ice-cold PBS and
fixed with 4% paraformaldehyde for 30 min at room
temperature. After washing with PBS, cells were
blocked using 1× Powerblock (Biogenex, San Ramon,
CA, USA) for 10 min and incubated with rabbit poly-
clonal TGF-ß1 antibody (1:50 in PBS, Santa Cruz)
overnight at 4C. The slide was carefully washed twice
with PBS and incubated with secondary antibody
(Rabbit Link, Biogenex) for 30 min, washed and
developed with Fast Red (Dako). Nuclei were counter-
stained with hematoxylin solution, then slides were
mounted using Aquatex (Merck) and analyzed under
light microscope.
Immunoblot
Cells were harvested in RIPA lysis buffer containing
complete protease inhibitor cocktail (Roche). Protein
concentration was determined by the BCA Assay.
Samples were mixed with 2× Laemmli buffer and
boiled. Equal amounts of protein (20 μg) were sepa-
rated on 12% SDS-polyacrylamide gel, transferred to
nitrocellulose membranes and blocked with 5% skim
milk in Tris-buffered saline (TBS), containing 0.1%
Tween-20. Membranes were incubated overnight at
4 °C with rabbit polyclonal TGF-ß1 (1:250, Santa
Cruz Biotechnology, Santa Cruz, USA) or mouse
monoclonal tubulin antibody (1:10,000, Sigma-
Aldrich), washed and incubated with peroxidase-
conjugated secondary antibody (anti-mouse IgG or
anti-goat IgG, 1:5000, Cell Signaling,). Blots were
visualized by ECL detection kit (Pierce Thermo).
Quantitative RT-PCR
IMCD cells for gene expression analysis were har-
vested with using 1 ml of Trizol reagent per well
(Life Technologies, USA) for phenol/chloroform ex-
traction of total RNA according to the manufacturer’s
protocol. For renal gene expression analysis, 100 mg
of whole kidneys were homogenized and total RNA
was isolated according to the manufacturer’s protocol
(SV Total RNA kit, Promega, Madison, WI, USA).
From both IMCD and kidney samples, 2 μg RNA was
reverse transcribed (High Capacity cDNA Reverse
Transcription kit, Applied Biosystems, Forster City,
CA, USA) using random primers. PCR reactions were
performed on a BioRad CFX thermal cycler (BioRad,
Hercules, CA, USA) using the Power SYBR Green
PCR Master Mix (Applied Biosystems). Specificity and
efficiency of the PCR reaction was confirmed with
melting curve and standard curve analysis, respect-
ively. Duplicate samples were normalized to
glyceraldehyde-3-phosphate dehydrogenase (Gapdh)
expression. Mean values are expressed with the
formula 2-ΔΔCt.
Mouse primer sequences were as follows: mCol3a1 for-
ward 5-TGGAAAAGATGGAACAAGTGG-3; mCol3a1
reverse 5-CCAGACTTTTCACCTCCAAC-3; mCol4a1
forward 5-CCTGCTAATATAGGGTTCGAG-3; mCol4a1
reverse 5-CCAGGCTTAAAGGGAAATCC-3; mEgr1 for-
ward 5-TTCAATCCTCAAGGGGAGCC-3; mEgr1 re-
verse 5-TAACTCGTCTCCACCATCGC-3; mTgfb1
forward 5-CACCATCCATGACATGAACC-3; mTgfb1 re-
verse 5-TCATGTTGGACAACTGCTCC-3.
Rat primer sequences were as follows: rCol3a1 for-
ward: 5-GAAGTCTCTGAAGCTGATGGG-3; rCol3a1
reverse: 5-GGCCTTGGGTGTTTGATATTC-3; rTgfb1
forward 5-ACCATCCATGACATGAACC-3; rTgfb1 re-
verse 5-TCATGTTGGACAACTGCTCC-3; rTimp1
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forward: 5-TTTCTGCAACTCGGACCTG-3; rTimp1 re-
verse: 5-ACAGCGTCGAATCCTTTGAG-3; rGapdh
forward: 5-CAATGACCCCTTCATTGACC-3; rGapdh
reverse: 5-CGCCAGTAGACTCCACAACA-3.
Primer sequences common for mouse and rat genes
were as follows: cFos forward 5-TTTCAACGCCGACTAC
GAGG-3; cFos reverse 5-GCGCAAAAGTCCTGTGTGT
T-3; cJun forward 5-GCACATCACCACTACACCGA-3;
cJun reverse 5-GGGAAGCGTGTTCTGGCTAT-3.
Statistics
All data are presented as mean ± SD. One-way analysis
of variance (ANOVA) followed by Tukey’s post-hoc test,
Kruskal-Wallis test followed by Dunn’s post-hoc test or
Mann-Whitney test were applied as appropriate with the
significance level set to p < 0.05 (SPSS 13 for Windows,
SPSS Inc., USA).
Results
Water restriction induces TGF-ß overexpression in the rat
medulla
During the 5 day follow-up, the body weight of both
controls and furosemide treated (hypoosmolar) rats
remained unchanged, but water restricted (hyperosmo-
lar) rats showed a moderate but significant weight loss
(Fig. 1a). The effectiveness of water restriction or fur-
osemide treatment was evaluated by daily urine volume
and urine osmolarity measurements at the beginning
(day 0) and at the end of the study (day 5). The volume
of twenty-four hour collected urine remained unchanged
in controls, whereas decreased dramatically in hyperos-
molar rats but increased in hypoosmolar (furosemide
treated) rats (Fig. 1a). The daily amount of excreted os-
motic material showed similar changes.
TGF-ß mRNA expression in the medulla of water
restriucted rats increased by 2-folds as compared to
control and furosemide treated rats (Fig. 1b), and
similar trend was observed by evaluation of TGF-ß
immunohistochemistry (Fig. 1c). We postulate the
relatively higher fold changes in TGF-ß protein ex-
pression as an activation of latent TGF-ß, in addition
to de novo TGF-ß synthesis. The inner stripe of the
outer medulla and fornix showed TGF-ß positive cells
only in water restricted rats (Fig. 1d, outer medulla,
see arrows), but no outer medullary staining in con-
trols and furosemide treated rats. In contrast, TGF-ß
immunohistochemistry did not show marked cytoplas-
mic immunoreactivity of the tubular epithelial cells in
the papilla and inner medulla of controls and
furosemide treated rats, but only interstitial staining.
Water restricted rats, however, depicted more inten-
sive cytoplasmic TGF-ß immunostaining in the inner
medulla (Fig. 1d, inner medulla).
Chronic increase in medullary osmotic concentration
induces overexpression of profibrotic transcription factors
Renal mRNA expression of the transcription factor
Egr-1 was more than seven-fold upregulated in rats
on water restriction, but remained at control levels in
furosemide treated rats (Fig. 2a). Additionally, Egr-1
immunohistochemistry revealed also a significant
amount of positive renal medullary cells in water
restricted rats, compared to barely no staining in con-
trols or furosemide treated animals (Fig. 2a–c). Inter-
estingly, Egr-1 staining in control and hypoosmolar
kidneys was restricted to tubular cells (Fig. 2c),
whereas in hyperosmolar kidneys we observed both
tubular (arrows) and interstitial (asterisk) Egr-1
expression.
Chronic water restriction led to more than six-fold
overexpression of the AP-1 component c-Fos. Inter-
estingly, water restriction did not alter c-Jun mRNA
expression, but furosemide reduced c-Jun expression
by 50% as compared to controls while had no effect
on cFos expression (Fig. 2d).
Similarly to cJun, type III collagen mRNA expression
was not altered by water restriction but was repressed by
furosemide treatment (Fig. 2e). However, the chronic
increase in medullary osmotic concentration in water re-
stricted rats induced TIMP-1 overexpression by 2-fold,
while the low osmotic concentration due to furosemide
treatment did not influence TIMP-1 (Fig. 2e).
Cell viability of IMCD cells decreases with
hyperosmolarity
Based on the in vivo results, we also wished to study the
effect of hyperosmolarity on IMCD cells. In vitro, the
progressive increase of osmolarity resulted in decreased
viability of IMCD cells as shown by MTT assay. Com-
pared to controls (at 330 mOsm), reaching 600 mOsm
in the medium led to 40% fall in viabilty, and a further
10% decrease was observed when we increased the
osmolarity to 900 mOsm (Fig. 3a).
Hyperosmolarity induces TGF-ß overexpression in IMCD
cells
In parallel with the decreased viability, we observed
marked increase in TGF-ß mRNA and protein
expressions due to hyperosmolarity. TGF-ß mRNA
expression increased from 330 mOsm to 600 mOsm
and from 600 to 900 mOsm by 1.5 fold and further
1.6 fold, respectively (Fig. 1b). This was accompanied
by a similar increase in TGF-ß protein expression by
3-fold and 2.4-fold, respectively (Fig. 3b). This obser-
vation was confirmed by immunocytochemistry as
well (Fig. 3c).
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Increased osmolarity induces the expression of
profibrotic genes in IMCD cells
As TGF-ß is one of the key growth factors that participate
in the pathomechanism of fibrosis, we investigated
whether its increased expression due to hyperosmolarity
could contribute to fibrotic gene expression in vitro. Sur-
prisingly, the progressive increase in osmotic concentra-
tion led to a gradual 2-fold increase in early growth
response factor-1 (Egr-1) expression, accompanied by
mild and late overexpression of collagen-3 but marked
and early overexpression of collagen-4 (Fig. 4a). The
mRNA expression of Egr-1 correlated well to TGF-ß
(p < 0.0001, Fig. 4b) but Egr-1 also correlated significantly
to both type III and type IV collagen expressions (Fig. 4b),
which indicates that hyperosmolarity might induce extra-
cellular matrix overproduction via activation of Egr-1.
The members of AP-1 transcription factor, c-Fos and
c-Jun were significantly upregulated at sustained hyper-
osmolarity reaching 900 mOsm, but remained
unchanged at 600 mOsm (Fig. 4c).
TGF-ß induces Egr-1 and collagen-IV production in IMCD
cells
In order to elucidate whether the overexpression of
profibrotic genes in IMCD cells under hyperosmolar en-
vironment are mainly a result of increased TGF-ß, we
investigated the effect of direct TGF-ß administration on
IMCD cells in normal osmolarity. TGF-ß treatment of
IMCD cells resulted in 2-fold increased Egr-1 mRNA
expression (Fig. 5a) accompanied by only mild, 30% in-
crease in type IV collagen expression (Fig. 5c). Surpri-
singly, type III collagen expression of TGF-ß treated
Fig. 1 Effect of increased or decreased medullary solute concentration in rats. a Compared to the initial body weights and to controls, both water restricted
and furosemide treated rats had significantly lower body weights at harvest. The urine volume dropped by 50% due to water restriction, but increased
almost 2-fold in furosemide treated rats, accompanied by significantly decreased or increased excretion of solutes, respectively. bWater restriction increased
mRNA expression of TGF-ß by 2-fold in the medulla, accompanied by marked TGF-ß immunostaining c, d, as compared to control and furosemide treated
rats. d The cytoplasm of outer medullary tubular epithelial cells were negative in controls and only weakly stained in furosemide treated rats, but no interstitial
staining was observed. However, water restriction increased the cytoplasmic TGF-ß staining intensity in several tubular cells in the inner stripe of the outer
medulla (red cytoplasm, see arrows). In contrast, TGF-ß immunostaining showed mostly interstitial staining in the inner medulla of controls and furosemide
treated rats, but also tubular cytoplasmic staining in water restricted rats (see insets, arrows pointing on positive cells). Primary antibody was omitted as
negative control for immunostaining. Data are presented as mean ± SEM, n = 6/group. * p < 0.05, ** p < 0.01, *** p < 0.001 (one-way ANOVA with Tukey’s
post-hoc test or Kruskal-Wallis test with Dunn’s post-hoc test)
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Fig. 2 Expression of profibrotic transcription factors due to chronic increased or decreased medullary solute concentration in rats. a Compared to control
rats, water restriction increased the medullary expression of Egr-1 mRNA and protein, while furosemide treated rats had similar expression levels to controls. b
The Egr-1 overexpression was confirmed by immunohistochemistry, depicting a significant amount of Egr-1 positive tubular cell nuclei in water restricted rats
(arrows), as compared to both control and furosemide treated rats. c Interestingly, apart of the tubular staining (arrows), we also found Egr-1 positive interstitial
cells only in the medulla of water restricted rats (asterisk). dWater restriction significantly increased the mRNA expression of the AP-1 component cFos. The
expression of the AP-1 component cJun did not change due to increased medullary solute concentration, but decreased by 50% after furosemide treatment.
e Increased medullary osmolarity had no effect on the mRNA expression of collagen-III, but it was reduced by furosemide treatment. As compared to
controls, the medullary TIMP-1 expression was almost 2-fold elevated after chronic water restriction, and furosemide did not alter TIMP-1. Data are presented
as mean ± SEM, n = 6/group. * p < 0.05, ** p < 0.01, *** p < 0.001 (Kruskal-Wallis test with Dunn’s post-hoc test)
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cells was similar to non-treated controls (Fig. 5b). This
experiment shows that even a mild hyperosmolarity of
600 mOsm exerts more potent effect on IMCD gene ex-
pression as compared to the potent profibrotic TGF-ß.
Discussion
The present study shows that sustained hypertonicity
induces the expression of TGF-ß and Egr-1 in the renal
medulla, both in vivo and in vitro. The renal medulla of
water restricted rats showed Egr-1 and AP-1 overexpres-
sion, increased amount of Egr-1 expressing tubules as
well as interstitial cells, which was abrogated by
furosemide treatment. Hypertonicity induced Egr-1 in
IMCD cells correlated with type III and type IV collagen
expressions but TGF-ß treatment resulted in only mild
type IV collagen overexpression. Our study shows that
sustained hypertonicity facilitates the production of
extracellular matrix components through Egr-1 overex-
pression and AP-1 activation.
It is well known that TGF-ß has a major impact on
kidney fibrosis [5, 6]. However, less is known about its
role in tubular function. TGF-ß is present in the inner
medulla, inhibiting sodium transport by the inner
medullary collecting duct (IMCD) cells [9]. TGF-ß can
induce the trascription of several genes, including the
transcription factor Egr-1 (early growth response factor-
Fig. 3 Effect of chronic increase in medium osmolarity on viability and TGF-ß expression of IMCD cells. a Chronic hyperosmolarity significantly
reduced the viability of IMCD cells (n = 8/group). b The expression of TGF-ß, however, increased dramatically both at mRNA and protein level
(n = 4/group). c Accordingly, immunocytochemistry depicted significant TGF-ß staining at 600 mOsm and even stronger staining at 900 mOsm
(n = 3/group). Data are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001 (one-way ANOVA with Tukey’s post-hoc test)
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1) which has been associated with upregulation of extra-
cellular matrix production [25, 26]. Egr-1 overexpression
of IMCD cells in vitro induced by acute changes in
osmolarity implicates an important role of Egr-1 in cel-
lular responses against osmolar stress. Short term (10 or
30 min) hyperosmotic urea treatment has been reported
to upregulate Egr-1 in IMCD cells [18–20]. On the other
hand, acute hypotonic stress of IMCD cells for 6 h also
increased Egr-1 expression [27].
In the renal medulla, a fluctuating but sustained
hypertonicity is present [28, 29], therefore we postulated
that osmotic concentration might regulate TGF-ß and
Egr-1 expression of renal medullary cells in vivo as well.
The sustained water restriction of rats induced overex-
pression of both TGF-ß and Egr-1 in the renal medulla,
accompanied by increased TIMP-1 and c-Fos expression.
These changes were completely abolished when the os-
motic gradient was washed out by furosemide treatment.
Water restriction increased the cytoplasmic TGF-ß
staining intensity in several tubular cells in both the
inner stripe of the outer medulla and inner medullary
tubules, and also increased the amount of Egr-1 positive
interstitial cells. However, collagen-III expression was
only repressed by furosemide treatment but did not alter
by water restriction. Interestingly, however, the TGF-ß
and Egr-1 producing cells were mainly localized to the
outer medulla and the fornix of the papilla, rather then
to the IMCD.
In our study, chronic, sustained hyperosmolarity
induced TGF-ß and Egr-1 overexpression in IMCD cells.
It has been shown previously that acute hyperosmolar
conditions lead to increased TGF-ß activity of rat kidney
fibrobast cells in vitro, without affecting mRNA or pro-
tein expression [13]. Our slightly different results could
be explained by the distinct cell type (IMCD vs fibro-
blast) and hyperosmolar conditions (chronic vs acute)
used. TGF-ß can induce the transcription of several
genes, including collagens and early response genes such
as Egr-1 [30]. However, Egr-1 might also induce TGF-ß
expression [14, 31] but also regulate the promoter of
other genes such as both type III and type IV collagens
[14, 32]. When we maintained IMCD cells in medium
Fig. 4 Effect of chronic hyperosmolarity on the expression of profibrotic genes and transcription factors in IMCD cells. a The progressive increase
of medium osmolarity induced overexpression of the Egr-1 mRNA. Mild type III collagen upregulation was induced only by 900 mOsm, dramatic
(6-fold) type IV collagen overexpression was observed at medium osmolarity of 600 mOsm. b Egr-1 and TGF-ß mRNA expressions showed the
strongest correlation. Both type III and type IV collagen expressions correlated well to the expression of the profibrotic Egr-1. c Components of
the transcription factor AP-1, cFos and cJun, were strongly overexpressed only at high osmolar concentration of 900 mOsm. Data are presented
as mean ± SEM, n = 4/group. * p < 0.05, ** p < 0.01 (Kruskal-Wallis test with Dunn’s post-hoc test)
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with normal osmolarity, TGF-ß treatment resulted in
increased Egr-1 expression, as expected, and a mild in-
crease in type IV collagen mRNA expression. As both
expression levels of Egr-1 and type IV collagen were less
marked in IMCD cells after TGF-ß treatment as com-
pared to hyperosmolarity, and TGF-ß treatment failed to
induce type III collagen expression, we postulate that
the interplay between TGF-ß and Egr-1 overexpressions
might be a key step promoting collagen synthesis in the
renal medulla under hyperosmolar conditions (Fig. 6).
In our in vitro treatment protocol we wished to resem-
ble the physiological environment of the renal medulla.
The murine inner medullary collecting duct cell line
(mIMCD-3) has been resported to retain most of the
characteristics of IMCD cells in vivo, including the
ability to adapt and grow in hypertonic medium in vitro
[33]. Previous reports on IMCD cell culture in hyperos-
molar or hypoosmolar environment used urea as the
osmotic stressor, since urea is membrane-permeant,
therefore it is not considered a hypertonic stressor as
compared to NaCl [29]. We treated the cells with the
combination of urea and NaCl for two reasons: first, we
wished to model the in vivo milieu as IMCD cells in the
Fig. 5 Effect of TGF-ß administration on IMCD cells under normal
osmotic concentration. TGF-ß administration for 48 h significantly
upregulated Egr-1 mRNA expression by 2-fold (a) but had no effect
on type III collagen expression (b). As compared to the effects of
increased osmotic concentration, TGF-ß administration induced only
a mild type IV collagen overexpression (c). Data are presented as
mean ± SEM, n = 3/group. * p < 0.05 (Mann-Whitney test)
Fig. 6 Proposed molecular effect of chronic osmotic stress on
collagen production. Osmotic stress induces the expression of
the profibrotic early growth response factor-1 (Egr-1), which can
directly induce the transcription of collagen-III and collagen-IV.
Hyperosmolarity also induces profibrotic TGF-ß expression, which
can lead to AP-1 activation through cFos and cJun, therefore
directly upregulate collagen expression. Egr-1 might also directly
activate cJun and promote further AP-1 activation. Moreover, we
postulate that TGF-ß and Egr-1 might induce each other in the
renal medulla (dotted arrows), enhancing their profibrotic effects
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renal papilla have contact with high concentration of
both urea and NaCl; second, the combination of urea
and NaCl significantly enhances IMCD cell survival as
compared to urea alone at 900 mOsm [34]. Further-
more, our method of gradually increasing medium
osmolarity for 6 days up to 900 mOsm allowed the cells
to slowly accomodate to the hyperosmolar environment
in contrast to previously reported acute hyperosmolar
stress models, where the majority of the cells would have
died within 24 h [34, 35]. Thus, we were able to study
the effects of sustained hyperosmolarity, which better
resembles the in vivo environment.
Taken together, sustained hyperosmolar conditions
induced Egr-1, TGF-ß and AP-1 expression in the
renal medullary cells both in vivo and in vitro. These
profibrotic factors upregulated, in turn, the gene ex-
pression of collagens, which was abrogated by
hypoosmolar conditions.
Conclusions
To the best of our knowledge, this is the first study
to show that sustained hyperosmolar conditions main-
tained by water restriction induced the expression of
Egr-1, TGF-ß and AP-1 component cFos in the renal
medulla, which might consequently upregulate the
gene expression of collagens. In vitro, sustained
hyperosmolarity increased the expression of Egr-1,
TGF-ß and collagens in IMCD cells. This indicates
that hyperosmolar milieu favors the biological pro-
cesses leading to fibrosis.
As a limitation, in this study we did not test the effect
of Egr-1 and/or TGF-ß inhibition during sustained
osmotic stress to IMCD cells. In addition, we observed
slightly different localization of Egr-1 and TGF-ß immu-
nostaining in the renal medulla versus the IMCD cells,
as a consequence of differences between our in vivo
versus in vitro model system [36].
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